Predict your next investment

HEALTHCARE | Biotechnology
biosource.com

See what CB Insights has to offer

Founded Year

1971

Stage

Acquired - II | Acquired

Revenue

$0000 

About BioSource International

BioOutsource is a provider of contract testing services to the global biopharmaceutical and biotechnology industries. The company's core offering includes a comprehensive suite of services which support the testing of biologic and vaccine products throughout development and manufacture.

BioSource International Headquarter Location

1 Technology Terrace Todd Campus

Glasgow, Scotland, G20 0XA,

United Kingdom

+44 (0)141 946 4222

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

BioSource International Patents

BioSource International has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/1/2008

8/23/2011

Fluid dynamics, Capacitors, Mass spectrometry, Ion source, Fluid mechanics

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/1/2008

00/00/0000

00/00/0000

Grant Date

8/23/2011

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Fluid dynamics, Capacitors, Mass spectrometry, Ion source, Fluid mechanics

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.